MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals

1 marketed · 1 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals

What are MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals's marketed drugs?

Top marketed products include APOKYN.

What is MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals's pipeline?

MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include apomorphine infusion.

Related